This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cerner Has Acquired Labotix Automation Inc.

Stock quotes in this article: CERN

KANSAS CITY, Mo. and PETERBOROUGH, Ontario, March 18, 2013 (GLOBE NEWSWIRE) -- Cerner (Nasdaq:CERN) today announced it has acquired Labotix ® Automation Inc., a leading provider of flexible, open automation solutions for the clinical laboratory setting.

The combination of Cerner Millennium ® , Cerner Copath, and Labotix' Automation will create the most comprehensive set of capabilities on the market to support high volume testing.

Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. "By aligning Labotix and Cerner ® solutions, Cerner is uniquely positioned with its automation options to support clients focusing on increasing laboratory processing capacity while reducing error," said Dr. John David Nolen, Managing Director of Laboratory Medicine for Cerner. "These capabilities are, and increasingly will be, important to organizations which have a business model for high volume or centralized laboratory business models."

Labotix Automation is an open automation solution, meaning it will work with all best of breed devices currently on the market. With installations around the world that have been operating and evolving for more than twenty years, Labotix Automation has the experience, expertise and reliability necessary to meet the needs of any size laboratory.

Since its inception in 1991, Labotix Automation has steadily grown its presence in the laboratory automation market. Cerner, an industry-leading health care company, will immediately offer Labotix Automation solutions to clients around the world and expects to drive increased value for laboratories through integration with Cerner's platforms.

"Cerner's dedication to providing clinical organizations with reliable, flexible and continuous innovation, combined with Labotix' automation solutions will further enable clinical laboratories to increase accuracy and efficiency to deliver better outcomes for individuals," said John Gustafson, CEO of Labotix Automation.

The acquisition is not expected to have a material impact on Cerner's 2013 financial results.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,042.90 -28.32 -0.17%
S&P 500 1,972.29 -5.51 -0.28%
NASDAQ 4,493.39 -12.4620 -0.28%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs